Urinary liver-type fatty acid binding protein is a biomarker reflecting renal damage and the ameliorative effect of drugs at an early stage of histone-induced acute kidney injury.
Ohata K, Sugaya T, Nguyen HN, Arai K, Hatanaka Y, Uno K, Tohma M, Uechi T, Sekiguchi K, Oikawa T, Nagabukuro H, Kuniyeda K, Kamijo-Ikemori A, Suzuki-Kemuriyama N, Nakae D, Noiri E, Miyajima K.
Ohata K, et al. Among authors: tohma m.
Nephrology (Carlton). 2024 Mar;29(3):117-125. doi: 10.1111/nep.14254. Epub 2023 Nov 11.
Nephrology (Carlton). 2024.
PMID: 37950597